ROIV
Roivant Sciences Ltd. Earnings
$14.17
Earnings Summary
Revenue | $2.17Mn |
Net Profits | $-223.36Mn |
Net Profit Margins | -10292.86% |
Roivant Sciences Ltd.’s revenue fell -96.06% since last year same period to $2.17Mn in the Q2 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -71.33% fall in its revenue since last 3-months.
Roivant Sciences Ltd.’s net profit fell -334.38% since last year same period to $-223.36Mn in the Q2 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -8.18% fall in its net profits since last 3-months.
Roivant Sciences Ltd.’s net profit margin fell -6054.71% since last year same period to -10292.86% in the Q2 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -277.37% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.31 |
EPS Estimate Current Year | -0.31 |
Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current quarter stand at -0.31 - a -24.7% fall from last quarter’s estimates.
Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current year stand at -0.31.
Key Ratios
Earning Per Share (EPS) | 0 |
Roivant Sciences Ltd.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Roivant Sciences Ltd. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-29 | -0.26 | -0.29 | -10.31% |
2025-08-11 | -0.25 | -0.25 | -1.58% |
2025-11-17 | -0.31 | 0 | 100% |
